<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997674/" ref="ordinalpos=1872&amp;ncbi_uid=6053801&amp;link_uid=PMC3997674" image-link="/pmc/articles/PMC3997674/figure/f1-ol-07-05-1327/" class="imagepopup">Figure 1.  From: TRAIL combinations: The new 'trail' for cancer therapy (Review). </a></div><br /><div class="p4l_captionBody">Dual opposing signaling pathways of TRAIL. (A) The apoptotic signaling pathway. (B) The resistance pathway developed against TRAIL-induced apoptosis. TRAIL, tumor necrosis factor-related apoptosis-inducing ligand.</div></div>